Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
55 hedge funds and large institutions have $159M invested in Apollo Endosurgery, Inc. in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 2 closing their positions.
789% more call options, than puts
Call options by funds: $845K | Put options by funds: $95K
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
26% more capital invested
Capital invested by funds: $127M → $159M (+$32.4M)
20% more funds holding
Funds holding: 46 → 55 (+9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$7.05M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$2.53M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.69M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.34M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$886K |
| 2 |
Renaissance Technologies
New York
|
-$359K |
| 3 |
Millennium Management
New York
|
-$289K |
| 4 |
GS
Gagnon Securities
New York
|
-$255K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$129K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Wells Fargo
San Francisco,
California
| $1K | +$327 | +38 | +44% |
|
|
RE
52
RBC Europe
London,
United Kingdom
| $9 | – | – | – |
|
|
53
Millennium Management
New York
| – | -$289K | -35,648 | Closed |
|
|
TSS
54
Two Sigma Securities
New York
| – | -$113K | -13,975 | Closed |
|
APEN Hedge Fund Activity: Q3 2021 in Review
55 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q3 2021, worth a combined $159M — up 26% from $127M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new APEN positions and 2 closed out — a net gain of 9 holders — while 19 added to existing stakes and 11 trimmed.
The largest buyer was Parian Global Management, opening a new position worth an estimated $7.05M. The largest seller was Manatuck Hill Partners, cutting an estimated $886K.
- 55 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q3 2021, up from 46 in Q2 2021.
- Funds reported $159M of Apollo Endosurgery, Inc. stock for Q3 2021, up 26% quarter-over-quarter.
- 11 funds opened new Apollo Endosurgery, Inc. positions in Q3 2021 and 2 closed out, a net change of +9 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q3 2021 was Parian Global Management, an estimated $7.05M added.
- The largest Apollo Endosurgery, Inc. seller in Q3 2021 was Manatuck Hill Partners, an estimated $886K sold.
Based on aggregated 13F filings for Q3 2021.